1. Home
  2. NRIX vs AGM Comparison

NRIX vs AGM Comparison

Compare NRIX & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$19.17

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$177.00

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
AGM
Founded
2009
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NRIX
AGM
Price
$19.17
$177.00
Analyst Decision
Strong Buy
Buy
Analyst Count
13
1
Target Price
$29.08
$219.00
AVG Volume (30 Days)
1.5M
88.5K
Earning Date
01-27-2026
02-20-2026
Dividend Yield
N/A
3.40%
EPS Growth
N/A
12.85
EPS
N/A
17.55
Revenue
$83,687,000.00
$377,946,000.00
Revenue This Year
$59.40
$14.80
Revenue Next Year
N/A
$9.98
P/E Ratio
N/A
$10.05
Revenue Growth
48.32
8.81
52 Week Low
$8.18
$155.00
52 Week High
$22.50
$212.24

Technical Indicators

Market Signals
Indicator
NRIX
AGM
Relative Strength Index (RSI) 58.69 53.99
Support Level $16.98 $171.27
Resistance Level $19.92 $180.50
Average True Range (ATR) 0.90 3.78
MACD -0.22 -0.51
Stochastic Oscillator 72.82 67.51

Price Performance

Historical Comparison
NRIX
AGM

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

Share on Social Networks: